Shares of Agilent Technologies, Inc. (NYSE:A) reached a new 52-week high during trading on Thursday . The stock traded as high as $65.21 and last traded at $65.16, with a volume of 646,999 shares. The stock had previously closed at $64.71.

A has been the topic of a number of research analyst reports. Wells Fargo & Company raised Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $42.92 to $60.73 in a research note on Wednesday, July 12th. BidaskClub upgraded Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Deutsche Bank AG set a $68.00 target price on Agilent Technologies and gave the company a “buy” rating in a research report on Wednesday, August 16th. Robert W. Baird lifted their target price on Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a research report on Wednesday, May 24th. Finally, J P Morgan Chase & Co restated an “overweight” rating and issued a $70.00 target price on shares of Agilent Technologies in a research report on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $63.91.

The company’s 50-day moving average is $61.64 and its 200-day moving average is $57.50. The company has a market cap of $20.94 billion, a P/E ratio of 33.53 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. Agilent Technologies’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post $2.32 EPS for the current fiscal year.

In related news, Director Boon Hwee Koh sold 4,500 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total value of $286,335.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Didier Hirsch sold 72,545 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Insiders have sold 141,098 shares of company stock valued at $8,798,933 in the last ninety days.

A number of institutional investors have recently modified their holdings of the business. Balentine LLC lifted its position in shares of Agilent Technologies by 2.9% during the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after purchasing an additional 50 shares in the last quarter. Sun Life Financial INC lifted its position in shares of Agilent Technologies by 26,144.4% during the second quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC lifted its position in shares of Agilent Technologies by 92.3% during the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Agilent Technologies by 5.3% during the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares in the last quarter. Finally, Trust Co. of Vermont lifted its position in shares of Agilent Technologies by 1.8% during the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after purchasing an additional 50 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “Agilent Technologies, Inc. (A) Hits New 1-Year High at $65.21” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/09/agilent-technologies-inc-a-hits-new-1-year-high-at-65-21.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.